Skip to main content
Fig. 3 | One Health Advances

Fig. 3

From: Ellagic acid supplementation ameliorates cisplatin-induced liver injury in mice by inhibiting the NF-κB pathway and activating the Nrf2/HO-1 pathway

Fig. 3

Changes in the MDA levels (A) and CAT (B) and SOD (C) activities in the livers of the mice. The results are shown as the mean ± S.D. (n = 8). A comparison between any two groups were performed, *p < 0.05, **p < 0.01, and *** p < 0.001. MDA: Malondialdehyde; CAT: Catalase; SOD: Superoxide dismutase

Back to article page

One Health Advances

ISSN: 2731-9970

Contact us